Literature DB >> 20449713

Protection from postischemic spinal cord injury by perfusion cooling of the epidural space during most or all of a descending thoracic or thoracoabdominal aneurysm repair.

Koichi Tabayashi1, Yoshikatsu Saiki, Hiroaki Kokubo, Goro Takahashi, Junetsu Akasaka, Seijirou Yoshida, Masaki Hata, Koki Niibori, Makoto Miura, Toshiaki Konnai.   

Abstract

OBJECTIVE: It is reported that hypothermia has some protective effect against ischemia of the spinal cord during thoracoabdominal aneurysm repair. However, it has not been elucidated clinically whether regional spinal cord hypothermia by epidural perfusion cooling is effective and safe. The purpose of this study was to assess the effect and safety of perfusion cooling of the epidural space during most or all of descending thoracic or thoracoabdominal aneurysm repair.
METHODS: From January 1998 to December 2007, a total of 102 patients with a mean age of 61 years underwent replacement of most or all of the descending thoracic aorta or thoracoabdominal aorta with the aid of mild hypothermia via epidural perfusion cooling and cerebrospinal fluid (CSF) drainage. Risk factors for spinal cord injury and hospital death were analyzed using univariate and multivariate analyses. The actuarial survival rate was calculated by the Kaplan-Meier method.
RESULTS: The mean lowest CSF temperature was 23.3 degrees C during epidural perfusion cooling. The mean temperature difference between the nasopharynx and CSF was 8.4 degrees C. The incidence of spinal cord injury was 3.9% (4/102), and that of hospital death was 5.9% (6/102). There was no significant risk factor associated with spinal cord injury. Type III aneurysm and postoperative cerebrovascular accident, respiratory failure, liver failure, and infection were predictors of hospital death. The actuarial survival rates at 3 and 5 years were 82.1% and 75.9%, respectively.
CONCLUSION: Epidural perfusion cooling is a safe method to employ in clinical situations. Our contemporary management strategies enabled patients to undergo thoracoabdominal aneurysm repair with excellent early and late survival and acceptable morbidity.

Entities:  

Mesh:

Year:  2010        PMID: 20449713     DOI: 10.1007/s11748-009-0495-0

Source DB:  PubMed          Journal:  Gen Thorac Cardiovasc Surg        ISSN: 1863-6705


  18 in total

1.  As originally published in 1993: Protection from postischemic spinal cord injury by perfusion cooling of the epidural space. Updated in 2001.

Authors:  K Tabayashi; N Motoyoshi
Journal:  Ann Thorac Surg       Date:  2001-03       Impact factor: 4.330

2.  Establishment of a local cooling model against spinal cord ischemia representing prolonged induction of heat shock protein.

Authors:  N Motoyoshi; M Sakurai; T Hayashi; M Aoki; K Abe; Y Itoyama; K Tabayashi
Journal:  J Thorac Cardiovasc Surg       Date:  2001-08       Impact factor: 5.209

3.  Open surgical repair of 2286 thoracoabdominal aortic aneurysms.

Authors:  Joseph S Coselli; John Bozinovski; Scott A LeMaire
Journal:  Ann Thorac Surg       Date:  2007-02       Impact factor: 4.330

4.  Analysis of motor and somatosensory evoked potentials during thoracic and thoracoabdominal aortic aneurysm repair.

Authors:  Kourosh Keyhani; Charles C Miller; Anthony L Estrera; Tara Wegryn; Roy Sheinbaum; Hazim J Safi
Journal:  J Vasc Surg       Date:  2008-10-01       Impact factor: 4.268

5.  Thoracic and thoracoabdominal aortic aneurysm repair using cardiopulmonary bypass, profound hypothermia, and circulatory arrest via left side of the chest incision.

Authors:  H J Safi; C C Miller; M H Subramaniam; M P Campbell; D C Iliopoulos; J J O'Donnell; M J Reardon; G V Letsou; R Espada
Journal:  J Vasc Surg       Date:  1998-10       Impact factor: 4.268

6.  Safety and efficacy of hypothermic cardiopulmonary bypass and circulatory arrest for operations on the descending thoracic and thoracoabdominal aorta.

Authors:  N T Kouchoukos; P Masetti; C K Rokkas; S F Murphy; E H Blackstone
Journal:  Ann Thorac Surg       Date:  2001-09       Impact factor: 4.330

7.  Strategies to prevent neurologic deficit based on motor-evoked potentials in type I and II thoracoabdominal aortic aneurysm repair.

Authors:  M J Jacobs ; S A Meylaerts; P de Haan; B A de Mol; C J Kalkman
Journal:  J Vasc Surg       Date:  1999-01       Impact factor: 4.268

8.  Panmyelic epidural cooling protects against ischemic spinal cord damage.

Authors:  M Marsala; I Vanicky; J Galik; J Radonak; I Kundrat; J Marsala
Journal:  J Surg Res       Date:  1993-07       Impact factor: 2.192

9.  Protection from postischemic spinal cord injury by perfusion cooling of the epidural space.

Authors:  K Tabayashi; K Niibori; H Konno; H Mohri
Journal:  Ann Thorac Surg       Date:  1993-09       Impact factor: 4.330

10.  Combined use of cerebral spinal fluid drainage and naloxone reduces the risk of paraplegia in thoracoabdominal aneurysm repair.

Authors:  C W Acher; M M Wynn; J R Hoch; P Popic; J Archibald; W D Turnipseed
Journal:  J Vasc Surg       Date:  1994-02       Impact factor: 4.268

View more
  4 in total

Review 1.  Current strategies for spinal cord protection during thoracic and thoracoabdominal aortic aneurysm repair.

Authors:  Hideyuki Shimizu; Ryohei Yozu
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-03-30

2.  Beneficial effects of local profound hypothermia and the possible mechanism after experimental spinal cord injury in rats.

Authors:  Xiaoyu Xu; Ning Li; Lin Zhu; Yuan Zhou; Huilin Cheng
Journal:  J Spinal Cord Med       Date:  2015-08-31       Impact factor: 1.985

3.  Regional hypothermia inhibits spinal cord somatosensory-evoked potentials without neural damage in uninjured rats.

Authors:  Ning Li; Lei Tian; Wei Wu; Huchen Lu; Yuan Zhou; Xiaoyu Xu; Xiangsheng Zhang; Huilin Cheng; Lihua Zhang
Journal:  J Neurotrauma       Date:  2013-07-16       Impact factor: 5.269

4.  Nanobubble technology to treat spinal cord ischemic injury.

Authors:  Masaaki Naganuma; Yuriko Saiki; Keisuke Kanda; Masatoshi Akiyama; Osamu Adachi; Akira Horii; Yoshikatsu Saiki
Journal:  JTCVS Open       Date:  2020-07-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.